NasdaqGS:BCRXBiotechs
Is Biocryst Pharmaceuticals (BCRX) Attractively Priced After Extended Share Price Weakness?
If you are trying to work out whether BioCryst Pharmaceuticals at around US$6.38 is priced attractively or not, it helps to first separate the recent share price moves from the underlying value story.
The stock has been under pressure recently, with returns of a 3% decline over the last 7 days, a 13.8% decline over the last 30 days, a 14.9% decline year to date, and a 26.8% decline over the last year. The 3 year and 5 year returns sit at 38.1% and 33.3% declines respectively.
Recent news...